FTH insider transactions
Faeth Therapeutics Inc. (FTH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
FTH insiders
Everyone who has filed a Form 4 or 5 at Faeth Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Anand Kiran ParikhPresident and CEO, Director+$55.4K
- Karen H VousdenDirector
- Josiah CraverPao
- Brian C StephensonChief Financial Officer+$1.13M
- Saira RamasastryDirector
- Stephen M. HahnDirector
- Christopher GerryPresident & PEO
- Phillip B. DonenbergDirector
- Bob HolmenDirector
- Cambrian BioPharma Inc10% owner+$2.5M-$788K
- James PeyerDirector, 10% owner+$2.51M-$788K
- Millennium Management LLC10% owner+$960K-$628K
- Thomas G RicksDirector+$250K
- Kristian HumerDirector
- William R RingoDirector
- John CelebiPresident and CEO, Director+$425
- Edward van der HorstChief Scientific Officer
- Stephanie KrebsChief Business Officer
- Jessie EnglishDirector
- Deneen VojtaDirector
- Erin ColganChief Financial Officer
- Patrick Stephen GallagherOfficer
- Samuel BroderDirector
- Apeiron Investment Group Ltd.10% owner+$3,539-$5.44M
- Robert Hamilton PierceOfficer-$568K